ATE279197T1 - Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln - Google Patents

Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln

Info

Publication number
ATE279197T1
ATE279197T1 AT00911536T AT00911536T ATE279197T1 AT E279197 T1 ATE279197 T1 AT E279197T1 AT 00911536 T AT00911536 T AT 00911536T AT 00911536 T AT00911536 T AT 00911536T AT E279197 T1 ATE279197 T1 AT E279197T1
Authority
AT
Austria
Prior art keywords
glaucomatus
prophylaxis
bladder
filtration
composition
Prior art date
Application number
AT00911536T
Other languages
German (de)
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Application granted granted Critical
Publication of ATE279197T1 publication Critical patent/ATE279197T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT00911536T 1999-02-25 2000-02-23 Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln ATE279197T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900672A SE9900672D0 (sv) 1999-02-25 1999-02-25 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
PCT/SE2000/000357 WO2000050040A1 (en) 1999-02-25 2000-02-23 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula

Publications (1)

Publication Number Publication Date
ATE279197T1 true ATE279197T1 (de) 2004-10-15

Family

ID=20414625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911536T ATE279197T1 (de) 1999-02-25 2000-02-23 Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln

Country Status (9)

Country Link
US (1) US6495563B1 (https=)
EP (1) EP1161245B1 (https=)
JP (1) JP2003521467A (https=)
AT (1) ATE279197T1 (https=)
AU (1) AU767411B2 (https=)
CA (1) CA2363131A1 (https=)
DE (1) DE60014869T2 (https=)
SE (1) SE9900672D0 (https=)
WO (1) WO2000050040A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162417A1 (en) * 2007-12-21 2009-06-25 Cook Incorporated Drug eluting ocular conformer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981880A (en) * 1969-03-14 1976-09-21 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
US3954844A (en) 1975-01-03 1976-05-04 G. D. Searle & Co. (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters
JPS58216155A (ja) * 1982-06-10 1983-12-15 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
DE3785602T2 (de) 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE3850676T2 (de) 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.
DE1300150T1 (de) * 1988-09-06 2003-09-18 Pharmacia Ab, Stockholm Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
DE68928551T2 (de) 1988-10-01 1998-04-23 Ueno Seiyaku Oyo Kenkyujo Kk Oculare hypotensive Mittel
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
SE9401087D0 (sv) * 1994-03-31 1994-03-31 Pharmacia Ab New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins

Also Published As

Publication number Publication date
SE9900672D0 (sv) 1999-02-25
DE60014869T2 (de) 2006-03-09
WO2000050040A1 (en) 2000-08-31
EP1161245B1 (en) 2004-10-13
EP1161245A1 (en) 2001-12-12
WO2000050040A8 (en) 2003-02-06
DE60014869D1 (de) 2004-11-18
AU3340200A (en) 2000-09-14
CA2363131A1 (en) 2000-08-31
US6495563B1 (en) 2002-12-17
JP2003521467A (ja) 2003-07-15
AU767411B2 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
ATE469613T1 (de) Implantat und verfahren zur behandlung einer implantatfläche
DE60222238D1 (de) Zusammensetzung und verfahren zur perkutanen superoxygenierung
ATE302017T1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
AU2002338483A1 (en) Drainage implant for draining aqueous humour from the anterior aqueous chamber of the eye into schlemm's canal
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60307607D1 (de) Verwendung von selektiven ep4 rezeptor agonisten zur behandlung von krankheiten
WO2003047513A3 (en) Method for treating ocular hypertension
WO2002098350A3 (en) Pyranoindazoles and their use for the treatment of glaucoma
EP1732484A4 (en) OPHTHALMIC IMPLANT FOR THE TREATMENT OF GLAUCOMA
EP1664011A4 (en) OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
WO2002102978A3 (en) Human growth hormone antagonists
IL152450A (en) Compounds and compositions for use in treating tnf-?? mediated conditions
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60222168D1 (de) Antagonisten der prostaglandin ep2 und/oder ep4 rezeptoren zur behandlung von menorrhagie
ATE279197T1 (de) Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln
DE60325377D1 (de) Motilidverbindungen
ATE369856T1 (de) Verfahren zur behandlung von glaukom
WO2004019874A3 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
WO2004054572A3 (en) Novel benzopyran analogs and their use for the treatment of glaucoma
RU99123236A (ru) Способ хирургического лечения открытоугольной глаукомы
PL368565A1 (en) Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
ZA200302911B (en) Method and composition for treatment of ocular hypertension and glaucoma.
ATE270883T1 (de) Verwendung von ap-1 aktivatoren zur behandlung von glaukom und erhöhtem augenblutdruck
FR2806293B1 (fr) Implants scleraux pour le traitement du decollement de retine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties